• OPEN AN ACCOUNT
Indian Indices
Nifty
25,492.30 -17.40
(-0.07%)
Sensex
83,216.28 -94.73
( -0.11%)
Bank Nifty
57,876.80 322.55
( 0.56%)
Nifty IT
35,117.65 -219.95
( -0.62%)
Global Indices
Nasdaq
46,931.02 -400.98
(-0.85%)
Dow Jones
6,741.06 -76.23
(-1.12%)
Hang Seng
50,211.07 -672.61
(-1.32%)
Nikkei 225
9,736.38 -40.70
(-0.42%)
Forex
USD-INR
88.65 -0.03
(-0.04%)
EUR-INR
101.82 -0.15
(-0.14%)
GBP-INR
115.54 -0.38
(-0.33%)
JPY-INR
0.58 0.00
(-0.08%)

EQUITY - MARKET SCREENER

Suditi Industries Ltd
Industry :  Textiles - Products
BSE Code
ISIN Demat
Book Value()
521113
INE691D01012
10.2058497
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUDITIND
34.38
228.78
EPS(TTM)
Face Value()
Div & Yield %
1.68
10
0
 

Aurobindo Pharma gains after arm incorporates new subsidiary in Chile
Oct 23,2025
The newly formed entity aims to expand Aurobindo Pharma’s pharmaceutical products business in Chile. The company stated that no governmental or regulatory approvals were required for the incorporation.

The subsidiary has been incorporated with an initial share capital of CLP 1,000,000 (approximately USD 1,050), divided into 100 shares with a nominal value of CLP 10,000 each. Eugia Pharma B.V. has subscribed to 100% of the share capital in cash, thereby holding full ownership of the Chilean entity.

Aurobindo Pharma is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services.

The company’s consolidated net profit tumbled 10.3% to Rs 824.75 crore despite a 4.5% increase in revenue from operations to Rs 7791.77 crore in Q1 FY26 over Q1 FY25.